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Research
AbstrACt
Objectives To undertake a systematic review and 
meta-analysis to evaluate the test performance including 
sensitivity and speciicity of rapid immunochromatographic 
syphilis (ICS) point-of-care (POC) tests at antenatal clinics 
compared with reference standard tests (non-treponemal 
(TP) and TP tests) for active syphilis in pregnant women.
Methods Five electronic databases were searched 
(PubMed, EMBASE, CRD, Cochrane Library and LILACS) to 
March 2016 for diagnostic accuracy studies of ICS test and 
standard reference tests for syphilis in pregnant women. 
Methodological quality was assessed using QUADAS-2 
(Quality Assessment of Diagnostic Accuracy Studies). 
A bivariate meta-analysis was undertaken to generate 
pooled estimates of diagnostic parameters. Results were 
presented using a coupled forest plot of sensitivity and 
speciicity and a scatter plot.
results The methodological quality of the ive included 
studies with regards to risk of bias and applicability concern 
judgements was either low or unclear. One study was judged 
as high risk of bias for patient selection due to exclusion of 
pregnant women with a previous history of syphilis, and one 
study was judged at high risk of bias for study low and timing 
as not all patients were included in the analysis. Five studies 
contributed to the meta-analysis, providing a pooled sensitivity 
and speciicity for ICS of 0.85 (95% CrI: 0.73 to 0.92) and 0.98 
(95% CrI: 0.95 to 0.99), respectively.
Conclusions This review and meta-analysis observed that 
rapid ICS POC tests have a high sensitivity and speciicity 
when performed in pregnant women at antenatal clinics. 
However, the methodological quality of the existing 
evidence base should be taken into consideration when 
interpreting these results.
PrOsPErO registration number CRD42016036335.
IntrOduCtIOn 
Syphilis is a chronic infectious disease, caused 
by the spirochete bacterium Treponema pall-
idum, transmitted sexually (acquired syphilis) 
and vertically (congenital syphilis) through 
the mother’s placenta to the fetus.1–3 Syphilis 
is among the high-risk conditions during preg-
nancy with possible serious birth outcomes if 
untreated or inadequately treated.1 4 
WHO estimates that syphilis infects 1% or 
more of antenatal care attendees in over 55 
countries. Approximately 950 000 pregnant 
women were infected with syphilis in 2012,5 
primarily in the low-income and middle-in-
come countries, sub-Saharan Africa, South-
east Asia and Latin America and the Caribbean 
(LAC). The prevalence of gestational syphilis 
in LAC varies from 0.08% to 7.0%6 7 between 
countries, and accounts for up to 25% of the 
2 million annual cases of gestational syphilis 
in these regions.6 7 Annually, an estimated 
100 000 stillbirths in these regions are attrib-
utable to congenital syphilis.6 7
Diagnosis of syphilis is complicated due 
to extremely difficult to cultivate T. pallidum 
in vitro. Clinical diagnosis, visualisation of 
treponemes in lesion material using dark-
field microscopy or immunofluorescent 
staining and serological reactions are used 
for diagnosis. Nevertheless, serological tests 
are a mainstay of syphilis diagnosis.8 9
Syphilis can be diagnosed serologically by 
using a non-treponemal (non-TP) test for 
screening and a TP test for the confirmation 
of results. TP tests are more sensitive and 
strengths and limitations of this study
 Ź This systematic review addresses the performance 
of rapid tests to tackle signiicant public health 
problems that are maternal and congenital syphilis.
 Ź The systematic review was conducted and presented 
in accordance with recognised standards for 
undertaking and reporting systematic reviews and
 Ź Methodological quality of studies was assessed 
using a validated method.
 Ź Data were synthesised using a bivariate random-
effects meta-analysis model, implemented in a 
Bayesian framework.
 Ź There were insuficient data from the included 
studies to undertake subgroup analyses. 
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more specific than non-TP tests, but they cannot distin-
guish between active and past infection, as antibodies 
remain circulating during life after treatment. Non-TP 
tests provide high sensitivity but not for the initial stage 
of primary syphilis or late period of disease (tertiary 
syphilis).8–10
In low-income and middle-income countries, many 
prenatal clinics that provide screening and treatment 
for syphilis do not have the capability to perform confir-
matory diagnostic tests, and so testing is frequently done 
off-site.11 Furthermore, patients may fail to return for 
laboratory results and both specimens and results have 
the potential to be lost in transit, resulting in treatment 
being delayed or missed.
Currently, new tests using cloned TP antigens and an 
immunochromatographic technique provide an alter-
native platform of rapid TP testing to be performed at 
point-of-care (POC), this is the immunochromatographic 
syphilis (ICS) test. The ICS test takes approximately 
20 min to perform and is generally considered fairly sensi-
tive and specific.8 In addition, the format of the test does 
not require the use of special equipment such as fluores-
cence microscopes or microplate readers, thus making it 
an ideal test for POC settings.12
A rapid syphilis test with immediate results implemented 
in a field setting has the advantage of allowing women 
who test positive to be treated on-site at the same visit, 
avoiding losses to follow-up for return visits and potential 
adverse outcomes associated with delayed treatment.13 
According to the Special Programme for Research and 
Training in Tropical Diseases (WHO),14 the ideal charac-
teristics of POC tests are that they are affordable, sensi-
tive, specific, user- friendly, rapid and robust.15 On-site 
screening services can contribute to significant declines 
in the prevalence of maternal and congenital syphilis in 
many low-income and middle-income countries,16 where 
operational research on POC syphilis testing is already 
underway.17
This systematic review and meta-analysis of diagnostic 
test accuracy aims to evaluate the performance of rapid 
ICS POC test at antenatal clinics compared with refer-
ence standard tests (non-TP and TP tests) for detecting 
active syphilis in pregnant women. Furthermore, 
in comparison to previous reviews by Tucker et al17 
and Jafari et al18 that included studies among women 
attending sexually transmitted infection (STI) clinics 
and antenatal clinics, the present systematic review 
includes only studies among pregnant women in ante-
natal care settings, that compare ICS rapid test with the 
algorithm established as reference standard (non-TP, 
following by TP test)10 used in many low-income and 
middle-income countries.
MEthOds
Protocol and guidelines
The protocol for this review can be found at PROSPERO 
2016: CRD42016036335, available from http://www. 
crd. york. ac. uk/ PROSPERO/ display_ record. asp? ID= 
CRD42016036335.
The systematic review was conducted and presented in 
accordance with the general principles recommended in 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement.19
search strategy
PubMed, EMBASE, CRD, Cochrane Library and 
LILACS (Literatura Latinoamericana en Ciencias de 
la Salud) were searched initially from January 1960 to 
end March 2016 and were updated to end August 2017. 
The following keywords were used: ‘pregnancy diseases; 
maternal syphilis; gestational syphilis; congenital syphilis’ 
and ‘diagnostic; screening; rapid test; serological test(s); 
point-of-care’ and ‘accuracy; sensitivity, specificity’. The 
update search also included the term ‘antenatal’. Full 
search strategies for PubMed and EMBASE databases are 
presented in online supplementary appendix 1. Filters for 
diagnostic studies recommended by Information Special-
ists’ Sub-Group Search Filter Resource (https:// sites. 
google. com/ a/ york. ac. uk/ issg- search- filters- resource/) 
were used. No language restrictions were applied to the 
search. Reference lists of all included studies were also 
searched.
Inclusion criteria for studies
Diagnostic test accuracy studies were included if they eval-
uated ICS POC tests for syphilis, compared with a standard 
reference test in pregnant women who receive antenatal 
care. We only included studies where the standard refer-
ence test comprised a non-TP test (Venereal Disease 
Research Laboratory (VDRL) or rapid plasma reagin 
(RPR)) followed by a TP test (T. pallidum haemaggluti-
nation test (TPHA), or fluorescent treponemal antibody 
absorbed (FTA-Abs), or T. pallidum particle agglutina-
tion (TPPA)). The standard reference test constitutes a 
non-TP test, followed by TP test where the non-TP test 
is positive. We also only included studies reporting test 
performance data (true positive, false positive, false nega-
tive, true negative) from which to calculate sensitivity and 
specificity, or other information from which we were able 
to calculate performance data. Dual tests such as HIV/
syphilis tests and TP/non-TP POC tests were not included 
in this review.
study selection process
All citations were downloaded to Mendeley reference 
management software (https://www. mendeley. com/ 
newsfeed/). Titles and abstracts were sifted by one 
reviewer (CNPRC) to identify potentially relevant articles. 
All potentially relevant articles obtained as full text were 
checked for inclusion by two reviewers (CNPRC, SH).
data extraction
Data were extracted by CNPRC using a prepiloted data 
extraction form in Excel and then checked by two inde-
pendent reviewers (RC and DSM). Any discrepancies 
were resolved by a third reviewer (MMS-J or SH). Details 
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of study characteristics, population characteristics, test 
descriptions and performance data outcomes (true posi-
tives, false positives, false negatives and true negatives; 
plus sensitivity and specificity) were extracted from the 
included studies.
Assessment of methodological quality
The quality of evidence was assessed and described 
using the Bristol University QUADAS-2 (Quality Assess-
ment of Diagnostic Accuracy Studies) tool to analyse risk 
of bias.20
QUADAS-2 is structured in four domains of potential 
sources of bias in primary diagnostic studies: ‘patient 
selection; index test; reference standard and flow and 
timing’. There are signalling questions within each of 
these domains, which drive researchers to overview the 
potential sources of bias.20
data analysis
The extracted data and quality assessment variables were 
presented for each study, both in structured tables and 
as a narrative description. The combined sensitivity and 
specificity was estimated using the bivariate random-ef-
fects meta-analysis model described by Reitsma et al.21 
The data synthesis was conducted under the assumption 
that different specific implementations of ICS rapid tests 
(eg, by different manufacturers) can be considered equiv-
alent. Therefore, there is essentially one index test only. A 
random-effects model was used to allow for heterogeneity 
between studies that is generally expected in studies of 
diagnostic test accuracy,22 which in this case will include 
heterogeneity due to differences in the specific index test 
used. Further details of the statistical model are provided 
in online supplementary appendix 2. Results were 
displayed as forest plots and scatter plots with 95% cred-
ible intervals (CrIs) and 95% prediction intervals (PrIs) 
for sensitivity and specificity.
Analyses were conducted in the R software environ-
ment23 using WinBUGS24 and R2WinBUGS software 
packages.25 Convergence to the target posterior distribu-
tions was assessed using the Gelman-Rubin convergence 
statistic.26 A burn-in of 10 000 iterations of the Markov 
chain was used with a further 10 000 iterations retained to 
estimate parameters.
rEsults
study selection process
The results of the study selection process are illustrated in 
figure 1 using a PRISMA flow diagram.19 Following dedu-
plication, the searches identified 484 citations of which 28 
were obtained for screening. Of these, 23 full-text publi-
cations were excluded. A table of these excluded studies 
with reasons for exclusion is presented in online supple-
mentary appendix 3. Five diagnostic accuracy studies 
were included in the review.
Characteristics of the included studies
The characteristics of the five included studies, including 
the study setting, study design, details of included partic-
ipants and details of the ICS and non-TP/TP tests are 
presented in online supplementary appendix 4.
All of the included studies were prospective, single-
gate (a study design in which only suspected patients for 
the target condition are recruited) diagnostic accuracy 
studies. Four studies reported consecutive sampling.27–30 
The sampling method was not reported in one study.31 All 
included studies were undertaken in antenatal clinics27–29 
or hospitals.30 31
All the studies were undertaken in low-income and 
middle-income countries (Brazil, South Africa, Mexico, 
India, Mozambique and Bolivia) according to the World 
Bank country classification.32 Two were undertaken in 
urban health centres30 31 and three at rural sites.27–29
Across the included studies the index tests used were 
ICS tests. Two studies28 30 used the Determine Syphilis TP 
test (Abbott Laboratories, Abbott Park, Illinois, USA), two 
studies29 31 used the SD Bioline V.3.0 test (Standard Diag-
nostics, Kyonggi-Korea) and one study27 used the VisiTect 
Syphilis test (Omega Diagnostics, Alloa, Scotland).
These ICS tests detect IgM, IgG and IgA antibodies and 
involve ICS in which one or multiple T. pallidum recom-
binant antigens are applied to nitrocellulose strips as a 
capture reagent. Antibodies in the specimen bound at 
antigen site on the strip and are revealed with dye bound 
anti-immunoglobulin or dye bound antigen and a posi-
tive reaction appears as a coloured line.9 The individual 
tests are also very similar in the assay procedure, taking 
from 20 to 30 min to get the result.
The age of participants was reported by three included 
studies,27 29 31 in which all women were in the third decade.
Across the five studies in pregnant women, three 
studies reported that participants were in the second 
trimester27–29 and one study reported that 16%, 32% and 
52% of participants were in the first, second and third 
trimester, respectively.31 One study in pregnant women 
did not report the stage of pregnancy.30
Obstetric characteristics were reported by two 
studies27 29 identifying: previous syphilis (n=4; 2.1%)27 and 
n=318; 7.1%),29 previous treatment for syphilis, including 
penicillin (n=51; 7.5%), a previous syphilis diagnosis 
(n=318; 7.1%)27 and prior partner syphilis history (as 
reported by the pregnant women) (n=228; 5.3%).29 Three 
studies did not report obstetric characteristics.28 30 31
For the Bronzan et al28 study, we analysed on-site ICS 
results for all the study participants (n=695) instead 
of on-site ICS results after training on how to properly 
obtain fingerstick blood (n=341). This study reported 
sensitivity and specificity both before and after nursing 
training on how to properly obtain fingerstick blood, 
(31.3%–85.7% and 94.8%–90.9%, respectively).28 None 
of the other included studies reported whether nurse 
training on how to properly obtain fingerstick blood 
was provided or not. As the inclusion criteria for studies, 
specified in the review protocol for this review, were not 
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based on whether training was provided or not, it was 
considered most appropriate to include results over the 
whole study period. Meta-analysis results including data 
from the Bronzan et al28 study after retraining on how to 
properly obtain fingerstick blood are also displayed for 
comparison.
In the Kashyap et al31 study, all patients received both 
VDRL and TPHA tests, however, TPHA was the confir-
matory test, and it was not clear how VDRL-negative/
TPHA-positive tests were interpreted. The authors were 
contacted for clarification, but without response to date.
Methodological quality of included studies
The overall methodological quality (risk of bias and appli-
cability concerns) of the five included studies assessed by 
QUADAS-2 is summarised in figure 2. Kashyap et al31 was 
judged as high risk of bias and high concern for patient 
selection as the study excluded pregnant women with 
previous history of syphilis. Montoya et al29 was judged 
at high risk of bias for study flow and timing as not all 
patients were included in the analysis. The remaining 
risk of bias and applicability concern judgements across 
studies were either low or unclear.
results reported by included studies
The diagnostic accuracy data reported by the five included 
studies are presented in table 1.
results of the meta-analysis
Five studies (14 985 participants) contributed to the 
meta-analysis. Figure 3 shows the sensitivity and spec-
ificity for each study, as estimated by the model. Note 
that the modelled estimates of sensitivity and specificity 
for each study are shrunken towards the overall mean, 
and hence differ from the raw estimates presented 
in table 1. The pooled sensitivity and specificity of ICS 
POC test compared with a standard reference test were 
0.85 (95% CrI 0.73 to 0.92) and 0.98 (95% CrI: 0.95 to 
0.99). The between-study SD for sensitivity and specificity 
were estimated to be 0.58 (95% CrI: 0.33 to 1.15) and 
0.71 (95% CrI: 0.42 to 1.47), respectively. The correlation 
between logit sensitivity and specificity was not statistically 
significant 0.42 (95% CrI: −0.46 to 0.88). The 95% PrIs 
Figure 1 Study selection following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.19
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of 0.57 to 0.96 (sensitivity) and 0.88 to 1.00 (specificity) 
suggest moderate uncertainty in predicting the sensitivity 
and specificity of a new study. Figure 4 presents the joint 
distribution for sensitivity and specificity.
Two sensitivity analyses were conducted. Assuming 
that missing test results in Benzaken et al27 were negative 
(rather than positive) reduced the pooled estimate of 
the sensitivity only slightly to 0.84 (95% CrI: 0.71 to 0.92) 
(online supplementary figure 1). The impact of retraining 
was assessed by including the data after training only 
from Bronzan et al,28 resulting in slightly higher sensitivity 
of 0.88 (95% CrI: 0.78 to 0.93) (online supplementary 
figure 2). See online supplementary appendix 5.
dIsCussIOn
This systematic review of the evidence for the diagnostic 
accuracy of TP antibody-based ICS tests among pregnant 
women with active syphilis included five studies (14 985 
participants). Although the ICS tests employed by the 
included studies are produced by different manufac-
turers, they are all similar in their implementation. As 
such, in order to assess the accuracy of ICS tests, estimates 
from all tests were pooled together in the meta-analysis.
We used an established algorithm of POC without 
confirmatory non-TP as a reference standard where a 
positive result indicates that immediate treatment is 
required for pregnant women.9 The meta-analysis was 
conducted under the assumption that the reference stan-
dard is 100% sensitive and specific.
The meta-analysis suggested a high average sensitivity 
0.85 (95% CrI: 0.73 to 0.92) and specificity 0.98 (95% 
CrI: 0.95 to 0.99) of the ICS tests, compared with standard 
tests (non-TP test followed by TP test where the non-TP 
test is positive). The high sensitivity of the ICS test indi-
cates that it might be a reasonable initial screening test 
for syphilis, but subsequent clinical management would 
require a non-TP test. Overall, we observed that rapid and 
POC tests performed well in both sensitivity and speci-
ficity compared with laboratory-based TP-specific tests 
such as TPPA and TPHA that have sensitivity in the range 
of 85%–100% and specificity of 98%–100%.33
The risk of bias and concerns over applicability of 
the five studies was either low or unclear. One study was 
judged as high risk of bias and high concern for patient 
selection as the study excluded pregnant women with 
previous history of syphilis.31 Another study was judged 
at high risk of bias for study flow and timing as not all 
patients were included in the analysis.29 The contribution 
of these studies to the pooled analysis should therefore 
be taken into consideration. A major limiting factor in 
assessing methodological quality was unclear or incom-
plete reporting by authors.
We undertook our review according to PRISMA guide-
lines, searched a wide range of data sources, undertook 
double data checking and assessed the methodological 
quality of the included studies using QUADAS-2. However, 
the presented review also has limitations. Although HIV 
status, clinical stage of syphilis infection and syphilis titre 
might influence ICS test performance,8 there were too 
few included studies, and insufficient data available from 
the included studies for us to explore these potential 
sources of heterogeneity. In one of the included studies,31 
Figure 2 Risk of bias and applicability concerns summary.
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Table 1 Diagnostic accuracy data reported by included studies
Author, year Non-TP, TP test T+ve F+ve F−ve T−ve Total
Sensitivity (95% CI)
Specificity (95% CI)
PPV (95% CI)
NPV (95% CI)
Syphilis 
prevalence (%)
Benzaken et al27 2011 VDRL, FTA-Abs 
assuming missing 
VDRL, n=8 test +ve
5 11 3 693 712 62.5% (24.5% to 91.5%)
98.4% (97.2% to 99.2%)
31.3% (11.0% to 58.7%)
99.6% (98.7% to 99.9%)
8/712 (1.12)
Assuming missing 
VDRL, n=6 test −ve
4 12 2 694 712 66.7% (22.3% to 95.7%)
98.3% (97.0% to 99.1%)
25.0% (7.3% to 52.4%)
99.7% (99.0% to 100.0%)
6/812 (0.84)
Bronzan et al28 2007
Before training on 
how to properly obtain 
ingerstick blood
RPR, TPHA 31 46 13 605 695 70.0% (56.0% to 0.82%)
92.9% (91.0% to 95.0%)
40.3% (29% to 52%)
97.9% (96% to 99%)
44/695 (6.33)
After training 20 2 29 290 341 90.9%
90.9%
40.8%
99.3%
22/341 (6.5)
Kashyap et al31 2015 VDRL, TPHA 3 0 1 196 200 75.0% (95% CI NR)
100.0%
100%
99.45% (95% CI NR)
4/200 (2.0)
Montoya et al29 2006 RPR, TPHA 326 131 55 3974 4486 86.0% (82.1% to 89.3%)
96.8% (96.2% to 97.3%)
71.0% (66.6% to 75.1%)
98.7% (98.3% to 99.0%)
381/4486 (8.5)
Tinajeros et al30 2006 RPR, TPPA 314 128 28 8422 8892 91.8% (88.4% to 94.5%)
98.5% (98.2% to 98.8%)
71.0% (66.6% to 75.2%)
99.7% (99.5% to 99.8%)
342/8892 (3.8)
F+ve, false positive; F− ve, false negative; FTA-Abs, luorescent treponemal antibody absorbed; Non-TP, non-treponemal; NPV, negative predictive value; 
NR, not registered; PPV, positive predictive value; RPR, rapid plasma reagin; T+ve, true positive; T-ve, true negative; TP, treponemal; TPHA, Treponema 
pallidum  haemagglutination test; TPPA; Treponema pallidum particle agglutination; VDRL, Venereal Disease Research Laboratory.
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it was also not clear how VDRL-negative/TPHA-positive 
tests were interpreted, which could potentially influence 
the performance results.
The present review only included studies that used 
the conventional algorithm of dual reference standard 
(non-TP and TP tests) as a reference standard. This is 
in contrast to the review by Tucker et al17 that included 
studies of one TP test or an additional non-TP test and 
the review by Jafari et al18 that included studies of TP tests, 
non-TP-specific tests or TP and non-TP-specific tests (the 
Figure 3 Sensitivity and speciicity of ICS point-of-care compared with a standard reference test. FN, false negative; FP, false 
positive; ICS, immunochromatographic syphilis; PrI, prediction interval; TN, true negative; TP, true positive.
Figure 4 Joint sensitivity and speciicity plot of immunochromatographic syphilis point-of-care compared with a standard 
reference test.
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inverse algorithm) but only presented a meta-analysis of 
studies evaluating a TP-specific reference standard test.
In comparison with the previous review by Tucker et al17 that 
included studies in women including sex workers attending 
STI clinics as well as antenatal clinics, the present review 
only included studies in pregnant women attending at any 
care settings (antenatal care settings, primary care settings, 
maternity hospital). In comparison with the previous review 
by Jafari et al18 that included studies in women attending 
antenatal clinic and sexually transmitted disease (STD) 
clinics. These differences in included studies are due to the 
main objective of the present review being to investigate the 
performance of on-site tests as part of prevention strategy of 
mother-to-child transmission of syphilis.
The review by Tucker et al17 reported that although 
there were variations in ICS test sensitivity across the 
included studies, that this variation was similar to sensi-
tivity noted in traditional non-TP testing where sensitivity 
ranged from 78% to 100%.17 From the meta-analysis 
in the review by Jafari et al,18 the authors observed that 
rapid and POC TP tests had varied sensitivity (74.26%–
86.34%)) and high specificity (95.85%–99.43%) (serum 
and blood) that were equal or better than laborato-
ry-based non-TP tests. Jafari et al18 synthesised results from 
individual studies separately for each index test, using a 
Bayesian hierarchical summary receiver operating char-
acteristic curve model and adjusted for imperfect refer-
ence standards.
Another difference between ours and these previous 
reviews is that for the Bronzan et al28 study (included in 
the reviews by Tucker et al17 and Jafari et al),18 we used 
the on-site ICS results for all the study participants 
(n=695), which was considered to be more consistent 
with the results of the other included studies, rather than 
the on-site ICS results after training on how to properly 
obtain fingerstick blood (n=341).
Our searches identified two studies27 31 that were 
published after the searches of previous reviews in the 
area.17 18
The update search also identified the recent system-
atic review and meta-analysis by RogoziĔska et al,34 which 
included two additional studies evaluating a qualitative 
RPR test as the index test.35 36
There were several differences in the QUADAS 
assessment reported by RogoziĔska et al34 compared 
with the present systematic review. Notable differences 
were that Kashyap et al31 was judged as high risk of bias 
and high concern for patient selection in the present 
review (unclear and low risk in RogoziĔska et al),34 and 
that Montoya et al29 was judged at high risk of bias for 
study flow and timing in the present review (low risk in 
RogoziĔska et al).34 Two reviewers were involved in the 
QUADAS assessment in RogoziĔska et al,34 whereas three 
reviewers (CNPRC, SH and MM-SJ) were involved in the 
present review.
The meta-analysis conducted by RogoziĔska et al34 
differed to that presented in the current review. Sepa-
rate meta-analyses were conducted according to the 
specific ICS test implementation (Determine, VisiTect, 
SD Bioline). Since a frequentist estimation framework 
was used, this meant that there were too few studies to fit 
a bivariate model in the case of two of the ICS implemen-
tations (Determine, VisiTect) and so separate meta-anal-
yses were conducted for sensitivity and specificity. For the 
current review, the synthesis was conducted under the 
assumption that different specific implementations of ICS 
rapid tests can be considered equivalent, and therefore 
combined in single meta-analysis model. The resulting 
pooled estimates represent the sensitivity/specificity of a 
general ICS test.
Public health strategies to prevent and treat maternal 
and fetal syphilis include early identification of infected 
individuals and high-risk populations, adequate treat-
ment, identification of infected partners and their treat-
ment, modification of high-risk behaviour and promoting 
the accessibility to and the use of healthcare.1 However, 
access to testing and implementing screening programmes 
varies significantly between countries and between rural 
and urban areas. ‘In primary healthcare settings, there 
are often technical difficulties associated with performing 
serological tests, such as retaining trained personnel and 
assuring that supplies are adequate and tests are of good 
quality’.8 Additionally, if pregnant women fail to return 
for laboratory results or they are lost in transit, the treat-
ment is delayed or missed.
COnClusIOns
This systematic review and meta-analysis observed that 
rapid ICS POC syphilis tests have a high sensitivity and 
specificity when performed in pregnant women at ante-
natal clinics. However, the methodological quality of the 
existing evidence and clinical heterogeneity of partici-
pants across studies should be taken into consideration.
Further diagnostic test accuracy of ICS POC tests at 
antenatal clinics compared with reference standard test 
that are reported in line with Standards for Reporting 
of Diagnostic Accuracy Studies37 would be of benefit, 
along with studies of duplex TP and non-TP rapid and 
POC tests. Studies evaluating the diagnostic test accu-
racy of STD coinfections such as HIV/Syphilis would 
also be of benefit. Considering the global efforts to elim-
inate congenital syphilis, the free access to simultaneous 
screening for these infections during pregnancy, through 
separate or dual tests, is crucial to tackle mother-to-child 
transmission of HIV and syphilis. Further studies that esti-
mate the coverage of screening programmes would also 
be beneficial to help reduce the reservoir of infections 
in communities to a level at which disease transmission 
cannot be sustained.
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